Canada to start to get Pfizer vaccines from the US next week

Canada to start to get Pfizer vaccines from the US next week
Canada Prime Minister Justin Trudeau speaks during a press conference in Ottawa, Friday, April 23, 2021, during the COVID-19 pandemic. (Sean Kilpatrick/The Canadian Press via AP)

Canada will start getting Pfizer COVID-19 vaccines from the United States next week, a company spokesperson said Friday, in what will be the first time the U.S. has allowed that company's vaccine exported to Canada.

Despite Canada's tightly woven commercial ties with the U.S., it has been getting Pfizer's vaccines from Belgium until now because U.S. authorities had kept supplies made in the U.S. for domestic use.

Prime Minister Justin Trudeau repeated Friday that starting next week, Canada will be receiving 2 million doses a week from Pfizer alone.

Vaccinations have ramped up in Canada in recent months. Every adult in Quebec will be eligible to make a vaccine appointment on May 14 and in Ontario, Canada's largest province, every adult can book an appointment starting May 24.

Trade-dependent Canada previously lagged on vaccinating its population of 38 million because it lacks the facilities to manufacture the itself.

Trudeau's government bet on seven different vaccines manufactured elsewhere and secured advance purchase agreements—enough to get 10 doses for each Canadian.. Regulators have approved the Pfizer, Moderna, AstraZeneca and Johnson & Johnson vaccines.

But initial supply chain difficulties forced Canada to extend the time between the first shot and the second by up to four months so that everyone can be protected faster with the primary dose. The hope is to get all adults at least one shot by the end of June.

© 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.

Citation: Canada to start to get Pfizer vaccines from the US next week (2021, April 30) retrieved 13 April 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Follow the latest news on the coronavirus (COVID-19) outbreak


Feedback to editors